BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Saturday, March 7, 2026
Home » Authors » Kim Coghill

Articles by Kim Coghill

Greenwood Named To Take Helm From Feldbaum As Head Of BIO

July 23, 2004
By Kim Coghill
WASHINGTON - U.S. Rep. Jim Greenwood, a Republican from Pennsylvania, retired from Congress Thursday to accept the position as president of the Biotechnology Industry Organization. (BioWorld Today)
Read More

Agensys, Genentech Enter Deal On Cancer Targets, Antibodies

July 23, 2004
By Kim Coghill

Greenwood Named To Take Helm From Feldbaum As Head Of BIO

July 23, 2004
By Kim Coghill
WASHINGTON - U.S. Rep. Jim Greenwood, a Republican from Pennsylvania, retired from Congress Thursday to accept the position as president of the Biotechnology Industry Organization. (BioWorld Today)
Read More

Agensys, Genentech Enter Deal On Cancer Targets, Antibodies

July 23, 2004
By Kim Coghill

ImClone Reports Erbitux Sales Of $71.4M, Plans sBLA Filing

July 22, 2004
By Kim Coghill
ImClone Systems Inc.'s stock fell 18.9 percent Wednesday even though the firm turned a profit on Erbitux sales and said it intends to request FDA approval of the drug in head and neck cancer. (BioWorld Today)
Read More

Seattle Genetics, Celera Join Up For Discovery Of Cancer Drugs

July 22, 2004
By Kim Coghill

ImClone Reports Erbitux Sales Of $71.4M, Plans sBLA Filing

July 22, 2004
By Kim Coghill
ImClone Systems Inc.'s stock fell 18.9 percent Wednesday even though the firm turned a profit on Erbitux sales and said it intends to request FDA approval of the drug in head and neck cancer. (BioWorld Today)
Read More

Seattle Genetics, Celera Join Up For Discovery Of Cancer Drugs

July 22, 2004
By Kim Coghill

FDA Considers Changes To Response Letters For Drugs

July 21, 2004
By Kim Coghill

Depomed Files NDA For Extended-Release Version Of Ciprofloxacin

July 21, 2004
By Kim Coghill
Previous 1 2 … 6 7 8 9 10 11 12 13 14 … 142 143 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for March 6, 2026.
  • Depression concept with human, broken brain and heavy rain

    CROI 2026 highlights depression and cognitive vulnerability in HIV

    BioWorld
    The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for March 3, 2026
  • University of Southern California reports new MAPT aggregation inhibitors

    BioWorld Science
    The University of Southern California has identified (2-oxo-2H-chromen-3-yl) scaffold-based carboxamide analogues acting as potent microtubule-associated protein...
  • Tanycytes in green capturing tau protein in red.

    Brain’s hidden tau-clearing pathway uncovered

    BioWorld Science
    Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing